31.18
-2.14(-6.42%)
Currency In USD
| Previous Close | 33.32 |
| Open | 33.36 |
| Day High | 33.46 |
| Day Low | 31.06 |
| 52-Week High | 62.53 |
| 52-Week Low | 24.1 |
| Volume | 1.17M |
| Average Volume | 1.02M |
| Market Cap | 2.92B |
| PE | -8.45 |
| EPS | -3.69 |
| Moving Average 50 Days | 32.41 |
| Moving Average 200 Days | 45.99 |
| Change | -2.14 |
If you invested $1000 in Crinetics Pharmaceuticals, Inc. (CRNX) since IPO date, it would be worth $1,272.13 as of May 13, 2025 at a share price of $31.18. Whereas If you bought $1000 worth of Crinetics Pharmaceuticals, Inc. (CRNX) shares 5 years ago, it would be worth $1,599.79 as of May 13, 2025 at a share price of $31.18.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Yesterday at 8:05 PM GMT
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 11, 2025 12:00 PM GMT
SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2025 financial results on Thursday, May 8, 2025 after the market closes. Company management will host a c
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Apr 10, 2025 9:04 PM GMT
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggre